Morgan Stanley Bioceres Crop Solutions Corp. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Bioceres Crop Solutions Corp. stock. As of the latest transaction made, Morgan Stanley holds 109,184 shares of BIOX stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,184
Previous 37,467
191.41%
Holding current value
$1.22 Million
Previous $514,000
168.87%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BIOX
# of Institutions
56Shares Held
12.5MCall Options Held
47.2KPut Options Held
6.4K-
Solel Partners LP Boston, MA4.58MShares$51.3 Million10.32% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.73MShares$19.4 Million3.3% of portfolio
-
Fourth Sail Capital LP Camana Bay Grand Cayman, E91.63MShares$18.2 Million6.15% of portfolio
-
Polar Capital Holdings PLC London, X01.25MShares$14 Million0.1% of portfolio
-
Uniplan Investment Counsel, Inc. Union Grove, WI458KShares$5.14 Million0.46% of portfolio
About Bioceres Crop Solutions Corp.
- Ticker BIOX
- Exchange NASDAQ
- Sector Basic Materials
- Industry Agricultural Inputs
- Shares Outstandng 61,918,400
- Market Cap $694M
- Description
- Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. ...